About Humonix Biosciences
Humonix Biosciences is a company based in Albany (United States) founded in 2014.. Humonix Biosciences has raised $250 thousand across 2 funding rounds from investors including Eastern New York Angels and SUNY Polytechnic Institute. Humonix Biosciences offers products and services including Retinal Vascular Dysfunction Model, Glaucoma Model, Pulmonary Fibrosis Model, and Pulmonary Arterial Hypertension Model. Humonix Biosciences operates in a competitive market with competitors including EyeCRO, Lexitas, Experimentica, Optimal Tracers and Ophthy-DS, among others.
- Headquarter Albany, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Humonix Biosciences, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$250 K (USD)
in 2 rounds
-
Latest Funding Round
$250 K (USD), Seed
Mar 23, 2015
-
Investors
Eastern New York Angels
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Humonix Biosciences
Humonix Biosciences offers a comprehensive portfolio of products and services, including Retinal Vascular Dysfunction Model, Glaucoma Model, Pulmonary Fibrosis Model, and Pulmonary Arterial Hypertension Model. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Biomimetic model for retina vasculature in drug testing applications.
Model for glaucoma research and drug development testing.
Model for pulmonary fibrosis research in development stage.
Model for pulmonary arterial hypertension in development for testing.
Funding Insights of Humonix Biosciences
Humonix Biosciences has successfully raised a total of $250K across 2 strategic funding rounds. The most recent funding activity was a Seed round of $250 thousand completed in March 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Seed — $250,000
-
First Round
First Round
(25 Apr 2014)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2015 | Amount | Seed - Humonix Biosciences | Valuation |
investors |
|
| Apr, 2014 | Amount | Grant - Humonix Biosciences | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Humonix Biosciences
Humonix Biosciences has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Eastern New York Angels and SUNY Polytechnic Institute. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Angel network for New York based startups
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Humonix Biosciences
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Humonix Biosciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Humonix Biosciences Comparisons
Competitors of Humonix Biosciences
Humonix Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as EyeCRO, Lexitas, Experimentica, Optimal Tracers and Ophthy-DS, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of in vivo and in vitro models for ophthalmic research
|
|
| domain | founded_year | HQ Location |
Clinical trials and medical strategies for ophthalmology products are provided.
|
|
| domain | founded_year | HQ Location |
Developing in vitro, ex vivo and in vivo preclinical ocular models
|
|
| domain | founded_year | HQ Location |
CRO focused on clinical research and tracer development services
|
|
| domain | founded_year | HQ Location |
Delivers comprehensive preclinical services to support drug development processes.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Humonix Biosciences
Frequently Asked Questions about Humonix Biosciences
When was Humonix Biosciences founded?
Humonix Biosciences was founded in 2014.
Where is Humonix Biosciences located?
Humonix Biosciences is headquartered in Albany, United States.
Is Humonix Biosciences a funded company?
Humonix Biosciences is a funded company, having raised a total of $250K across 2 funding rounds to date. The company's 1st funding round was a Grant of $100K, raised on Apr 25, 2014.
What does Humonix Biosciences do?
Humonix Biosciences, established in 2014, excels in providing healthcare solutions, biopharma outsourcing, cro, preclinical studies, and ophthalmology. CRO focused on ophthalmic drugs development services. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide. It continues to evolve, meeting industry challenges with strategic approaches.
Who are the top competitors of Humonix Biosciences?
Humonix Biosciences's top competitors include Lexitas, EyeCRO and Optimal Tracers.
What products or services does Humonix Biosciences offer?
Humonix Biosciences offers Retinal Vascular Dysfunction Model, Glaucoma Model, Pulmonary Fibrosis Model, and Pulmonary Arterial Hypertension Model.
Who are Humonix Biosciences's investors?
Humonix Biosciences has 2 investors. Key investors include Eastern New York Angels, and SUNY Polytechnic Institute.